{
    "code": "02019438",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02019438",
    "time": "2015-08-23 10:33:55",
    "許可證字號": "衛署藥輸字第019438號",
    "註銷狀態": "已註銷",
    "註銷日期": "91\/05\/01",
    "註銷理由": "證別變更",
    "有效日期": "91\/08\/24",
    "發證日期": "81\/08\/24",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201943807",
    "中文品名": "惠爾血添",
    "英文品名": "FILGRASTIN INJECTION 150UG\/0.6ML",
    "適應症": "１．動員造血幹細胞至周邊血中。２．促進造血幹細胞移植時嗜中性白血球數的增加。３．癌症化學療法所引起之嗜中性白血球減少症。４．骨髓發育不良症候群的嗜中性白血球缺乏症。５．先天症、特異性嗜中性白血球缺乏症。",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "FILGRASTIM",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1902001100  麒麟藥品股份有限公司",
    "申請商地址": "台北巿中山北路二段４４號１６樓",
    "主製造廠": {
        "製造廠名稱": "F260472000  KIRIN BREWERY CO., LTD. TAKASAKI PHARMACEUTICAL PLANT",
        "製造廠廠址": "100-1, HAGIWARA-MACHI TAKASAKI-SHI, GUNM 370.10-1, SHINKAWA 2 CHO-ME, CHUO-KU TOKYO 104 JAPAN",
        "製造廠公司地址": "10-1, SHINKAWA 2 CHO-ME, CHUO-KU TOKYO 104 JAPAN",
        "製造廠國別": "JAPAN",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1002000500",
            "成分名稱": "FILGRASTIM",
            "含量描述": "150",
            "含量": "150.0000000000",
            "單位": "MCG"
        }
    ]
}